Literature DB >> 30939030

Therapeutic Targeting of High-Mobility Group Box-1 in Pulmonary Arterial Hypertension.

Neil M Goldenberg1,2, Yijie Hu3,4, Xudong Hu3, Allen Volchuk3, Yidan D Zhao5, Mariya M Kucherenko6,7,8, Christoph Knosalla7,8, Marc de Perrot5, Kevin J Tracey9, Yousef Al-Abed9, Benjamin E Steinberg1,2, Wolfgang M Kuebler2,6,8,10.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30939030      PMCID： PMC7125426          DOI： 10.1164/rccm.201808-1597LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  10 in total

Review 1.  HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease.

Authors:  Helena Erlandsson Harris; Ulf Andersson; David S Pisetsky
Journal:  Nat Rev Rheumatol       Date:  2012-01-31       Impact factor: 20.543

2.  Modern age pathology of pulmonary arterial hypertension.

Authors:  Elvira Stacher; Brian B Graham; James M Hunt; Aneta Gandjeva; Steve D Groshong; Vallerie V McLaughlin; Marsha Jessup; William E Grizzle; Michaela A Aldred; Carlyne D Cool; Rubin M Tuder
Journal:  Am J Respir Crit Care Med       Date:  2012-06-07       Impact factor: 21.405

Review 3.  Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension.

Authors:  Marlene Rabinovitch; Christophe Guignabert; Marc Humbert; Mark R Nicolls
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

4.  The Role of the Human Immune System in Chronic Hypoxic Pulmonary Hypertension.

Authors:  Yijie Hu; Diana Zabini; Wei Gu; Neil M Goldenberg; Siegfried Breitling; Golam Kabir; Kim A Connelly; Wolfgang M Kuebler
Journal:  Am J Respir Crit Care Med       Date:  2018-08-15       Impact factor: 21.405

5.  Toll-like receptor 4-deficient mice are resistant to chronic hypoxia-induced pulmonary hypertension.

Authors:  Karen C Young; Sameh M A Hussein; Rita Dadiz; Daphne deMello; Carlos Devia; Dorothy Hehre; Cleide Suguihara
Journal:  Exp Lung Res       Date:  2010-03       Impact factor: 2.459

6.  High mobility group box 1 contributes to the pathogenesis of experimental pulmonary hypertension via activation of Toll-like receptor 4.

Authors:  Eileen M Bauer; Richard Shapiro; Han Zheng; Ferhaan Ahmad; David Ishizawar; Suzy A Comhair; Serpil C Erzurum; Timothy R Billiar; Philip M Bauer
Journal:  Mol Med       Date:  2013-02-08       Impact factor: 6.354

7.  MD-2 is required for disulfide HMGB1-dependent TLR4 signaling.

Authors:  Huan Yang; Haichao Wang; Zhongliang Ju; Ahmed A Ragab; Peter Lundbäck; Wei Long; Sergio I Valdes-Ferrer; Mingzhu He; John P Pribis; Jianhua Li; Ben Lu; Domokos Gero; Csaba Szabo; Daniel J Antoine; Helena E Harris; Doug T Golenbock; Jianmin Meng; Jesse Roth; Sangeeta S Chavan; Ulf Andersson; Timothy R Billiar; Kevin J Tracey; Yousef Al-Abed
Journal:  J Exp Med       Date:  2015-01-05       Impact factor: 14.307

8.  HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling.

Authors:  Allan Tsung; John R Klune; Xianghong Zhang; Geetha Jeyabalan; Zongxian Cao; Ximei Peng; Donna B Stolz; David A Geller; Matthew R Rosengart; Timothy R Billiar
Journal:  J Exp Med       Date:  2007-11-05       Impact factor: 14.307

9.  Metabolomic heterogeneity of pulmonary arterial hypertension.

Authors:  Yidan Zhao; Jenny Peng; Catherine Lu; Michael Hsin; Marco Mura; Licun Wu; Lei Chu; Ricardo Zamel; Tiago Machuca; Thomas Waddell; Mingyao Liu; Shaf Keshavjee; John Granton; Marc de Perrot
Journal:  PLoS One       Date:  2014-02-12       Impact factor: 3.240

10.  Inflammation and autoimmunity in pulmonary hypertension: is there a role for endothelial adhesion molecules? (2017 Grover Conference Series).

Authors:  Wolfgang M Kuebler; Sébastien Bonnet; Arata Tabuchi
Journal:  Pulm Circ       Date:  2018-02-26       Impact factor: 3.017
  10 in total
  13 in total

1.  Update in Pulmonary Vascular Diseases and Right Ventricular Dysfunction 2019.

Authors:  Elena A Goncharova; Stephen Y Chan; Corey E Ventetuolo; Norbert Weissmann; Ralph T Schermuly; Christopher J Mullin; Mark T Gladwin
Journal:  Am J Respir Crit Care Med       Date:  2020-07-01       Impact factor: 21.405

2.  HIMF (Hypoxia-Induced Mitogenic Factor) Signaling Mediates the HMGB1 (High Mobility Group Box 1)-Dependent Endothelial and Smooth Muscle Cell Crosstalk in Pulmonary Hypertension.

Authors:  Qing Lin; Chunling Fan; Jose Gomez-Arroyo; Katrien Van Raemdonck; Lucas W Meuchel; John T Skinner; Allen D Everett; Xia Fang; Andrew A Macdonald; Kazuyo Yamaji-Kegan; Roger A Johns
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-10-10       Impact factor: 8.311

3.  Necrosis-Released HMGB1 (High Mobility Group Box 1) in the Progressive Pulmonary Arterial Hypertension Associated With Male Sex.

Authors:  Marina Zemskova; Nolan McClain; Maki Niihori; Mathews V Varghese; Joel James; Ruslan Rafikov; Olga Rafikova
Journal:  Hypertension       Date:  2020-10-05       Impact factor: 10.190

Review 4.  Redox Regulation, Oxidative Stress, and Inflammation in Group 3 Pulmonary Hypertension.

Authors:  Olena Rudyk; Philip I Aaronson
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  A Novel Peptide for Immunomodulation in Pulmonary Arterial Hypertension.

Authors:  Daniel Grinnan; Laszlo Farkas
Journal:  Am J Respir Crit Care Med       Date:  2019-06-15       Impact factor: 21.405

Review 6.  Inflammasome Activation in Pulmonary Arterial Hypertension.

Authors:  Anna Foley; Benjamin E Steinberg; Neil M Goldenberg
Journal:  Front Med (Lausanne)       Date:  2022-01-13

Review 7.  When Innate Immunity Meets Angiogenesis-The Role of Toll-Like Receptors in Endothelial Cells and Pulmonary Hypertension.

Authors:  Aneel Bhagwani; A A Roger Thompson; Laszlo Farkas
Journal:  Front Med (Lausanne)       Date:  2020-07-31

8.  Indirect regulation of HMGB1 release by gasdermin D.

Authors:  Allen Volchuk; Anna Ye; Leon Chi; Benjamin E Steinberg; Neil M Goldenberg
Journal:  Nat Commun       Date:  2020-09-11       Impact factor: 14.919

Review 9.  Targeting Inflammation Driven by HMGB1.

Authors:  Huan Yang; Haichao Wang; Ulf Andersson
Journal:  Front Immunol       Date:  2020-03-20       Impact factor: 7.561

Review 10.  Perivascular Inflammation in Pulmonary Arterial Hypertension.

Authors:  Yijie Hu; Leon Chi; Wolfgang M Kuebler; Neil M Goldenberg
Journal:  Cells       Date:  2020-10-22       Impact factor: 6.600
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.